Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Constantinescu CS, Asher A, Fryze W, Kozubski W, Wagner F, Aram J, Tanasescu R, Korolkiewicz RP, Dirnberger-Hertweck M, Steidl S, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e117. Epub 2015 May 21. PMID: 26185773. Abstract CommentRecommendBookmarkWatch